Adipokine in Metabolic Liver Disease: Adipo-Brain-Liver Cross talk. [PDF]
Su Y +12 more
europepmc +1 more source
ABSTRACT Aims Type 2 diabetes drives the progression of metabolic dysfunction‐associated steatohepatitis (MASH). We evaluated whether antidiabetic therapy, specifically adding sodium–glucose cotransporter 2 (SGLT2) inhibitor to a glucagon‐like peptide‐1 receptor agonist (GLP‐1RA), improves liver histology in adults with biopsy‐proven MASH and type 2 ...
Teruki Miyake +14 more
wiley +1 more source
National divergence in cardio-kidney-metabolic syndrome burden and implications for health policy: a global burden of disease analysis with projections to 2050. [PDF]
Li L, Chen H, Liu P, Jia Z.
europepmc +1 more source
ABSTRACT Background and Aims Weight loss after metabolic bariatric surgery (MBS) is heterogeneous, and the contribution of liver histology and genetic susceptibility to insufficient weight loss (IWL) or weight regain (WR) remains unclear. We assessed the prevalence of IWL and WR after MBS and their association with liver histology and metabolic ...
Felice Cinque +18 more
wiley +1 more source
Association Between Non-alcoholic Fatty Liver Disease and Subclinical Atherosclerosis Assessed by Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis. [PDF]
Akter N +8 more
europepmc +1 more source
Adipokine Profile in Non-alcoholic Fatty Liver Disease. [PDF]
C T, N PK, Ch N, Chinnapaka M, Thota RK.
europepmc +1 more source
ABSTRACT Aims This study quantified the real‐world healthcare costs and utilisation associated with diagnosed metabolic dysfunction‐associated steatotic liver disease (MASLD) among adults with Type 2 diabetes (T2D). Methods We conducted a retrospective cohort study using IQVIA PharMetrics Plus Closed Health Plan data from January 2016 to June 2025 ...
Tien Hoang Tran +3 more
wiley +1 more source
Sonographic Grading of Non-alcoholic Fatty Liver Disease and Its Association With Serum Biomarkers, Echocardiography, and Electrocardiogram. [PDF]
Reddy C, L MMB, A S, Prasad S, Reddy CM.
europepmc +1 more source
ABSTRACT Aims Adults with obesity are at increased risk of metabolic dysfunction‐associated steatotic liver disease (MASLD)‐related fibrosis, but the diagnostic performance of non‐invasive tests (NITs) in this population remains uncertain. This meta‐analysis evaluated NITs for detecting significant (≥F2) and advanced (≥F3) fibrosis in adults with ...
Patricia M. Ortega +5 more
wiley +1 more source
The association between oral hygiene and metabolic dysfunction-associated steatotic liver disease - a systematic review. [PDF]
Gerold A, Walter FS, Waller J, Ferger B.
europepmc +1 more source

